Professor David Denning addresses the 8th AAA in Lisbon (Photo by Luisa Morlano)

Aspergillosis, lung and sinus disease caused by the fungus Aspergillus, affects around 15 million people and kills over 1 million each year.

Announced at the 8th biennial Advances against Aspergillosis international conference in Lisbon starting on February 1st 2018, are the 5 aspirational targets for aspergillosis to be achieved by 2030:

1.) Survival in invasive aspergillosis increased to 90% (up from under 50%)

2.) Plugging the major gaps in our understanding of the biological, immunological and genetic basis of aspergillosis

3.) Diagnostics (most countries, including all of Africa have no diagnostic capability at all)
• New widely available, standardized and clinically validated diagnostics techniques
• New simple screening tests developed